Business Description
WuXi XDC Cayman Inc
ISIN : KYG9808A1058
Compare
Compare
Traded in other countries / regions
02268.Hong KongL74.Germany IPO Date
2023-11-20Description
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 50.64 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.09 | |||||
| Interest Coverage | 1460.48 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 17.54 | |||||
| Beneish M-Score | -1.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 181.1 | |||||
| 3-Year EBITDA Growth Rate | 110 | |||||
| 3-Year EPS without NRI Growth Rate | 148.8 | |||||
| 3-Year FCF Growth Rate | -87.2 | |||||
| 3-Year Book Growth Rate | 136.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 46.28 | |||||
| Future 3-5Y Total Revenue Growth Rate | 44.62 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.39 | |||||
| 9-Day RSI | 70.42 | |||||
| 14-Day RSI | 67.59 | |||||
| 6-1 Month Momentum % | 58 | |||||
| 12-1 Month Momentum % | -13.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.13 | |||||
| Quick Ratio | 4.02 | |||||
| Cash Ratio | 2.75 | |||||
| Days Inventory | 14.37 | |||||
| Days Sales Outstanding | 118.48 | |||||
| Days Payable | 113.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.5 | |||||
| Shareholder Yield % | 0.02 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.95 | |||||
| Operating Margin % | 22.04 | |||||
| Net Margin % | 21.19 | |||||
| FCF Margin % | -30.55 | |||||
| ROE % | 13.49 | |||||
| ROA % | 10.59 | |||||
| ROIC % | 24.78 | |||||
| ROC (Joel Greenblatt) % | 47.37 | |||||
| ROCE % | 16.1 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 59.92 | |||||
| Forward PE Ratio | 32.59 | |||||
| PE Ratio without NRI | 50.56 | |||||
| PS Ratio | 12.48 | |||||
| PB Ratio | 5.89 | |||||
| Price-to-Tangible-Book | 6.2 | |||||
| EV-to-EBIT | 44.78 | |||||
| EV-to-EBITDA | 41.28 | |||||
| EV-to-Revenue | 11.34 | |||||
| EV-to-FCF | -37.25 | |||||
| Price-to-Graham-Number | 3.71 | |||||
| Price-to-Net-Current-Asset-Value | 9 | |||||
| Price-to-Net-Cash | 16.43 | |||||
| Earnings Yield (Greenblatt) % | 2.23 | |||||
| FCF Yield % | -2.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
WuXi XDC Cayman Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 358.408 | ||
| EPS (TTM) (€) | 0.063 | ||
| Beta | 0 | ||
| Volatility % | 68.77 | ||
| 14-Day RSI | 67.59 | ||
| 14-Day ATR (€) | 0.092746 | ||
| 20-Day SMA (€) | 3.453 | ||
| 12-1 Month Momentum % | -13.38 | ||
| 52-Week Range (€) | 1.45 - 3.84 | ||
| Shares Outstanding (Mil) | 1,198.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
WuXi XDC Cayman Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
WuXi XDC Cayman Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
WuXi XDC Cayman Inc Frequently Asked Questions
What is WuXi XDC Cayman Inc(FRA:L74)'s stock price today?
The current price of FRA:L74 is €3.78. The 52 week high of FRA:L74 is €3.84 and 52 week low is €1.45.
When is next earnings date of WuXi XDC Cayman Inc(FRA:L74)?
The next earnings date of WuXi XDC Cayman Inc(FRA:L74) is .
Does WuXi XDC Cayman Inc(FRA:L74) pay dividends? If so, how much?
WuXi XDC Cayman Inc(FRA:L74) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers